the role of novel therapies in r/r dlbcl
Published 2 years ago • 82 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
0:57
novel therapeutic strategies in all
-
2:03
novel treatment approaches for early-stage dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
1:15
r/r dlbcl challanges: novel therapeutics
-
34:12
golden innovations: nanocrystal therapies for als and ms with clene nanomedicines’ dr. karen ho
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:00
novel treatment strategies in myelofibrosis
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:45
improving the frontline treatment of dlbcl
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
4:59
a breakthrough therapy: polatuzumab vedotin plus br for r/r dlbcl